Navigation Links
GeneNews Announces First Quarter Results
Date:5/2/2008

TORONTO, May 2 /PRNewswire-FirstCall/ - GeneNews Limited (TSX: GEN), a company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, today reported operational and financial results for the first quarter ended March 31, 2008.

"During the quarter, we achieved several of the key milestones necessary to support the commercialization of our first product, ColonSentry(TM), a risk stratification test for colorectal cancer," said Dr. K. Wayne Marshall, President and CEO of GeneNews. "We remain on track to launch the laboratory-developed test (LDT) version of ColonSentry(TM) in the third quarter of 2008. The test will be administered as a service by our in-house clinical reference lab located at our headquarters just north of Toronto, Canada. This novel test will initially target the estimated 1.5 million people over the age of 50 in the Greater Toronto Area who should be screened for colorectal cancer, the vast majority of whom do not currently comply with screening guidelines."

Highlights in the first quarter:

- Reported positive results from a validation study of a panel of

six colorectal cancer biomarkers, confirming (p<0.05) that

the panel was able to stratify a population with average risk for

colorectal cancer into three defined risk groups (Increased, Average,

and Decreased Probability). The results were presented in a Late

Breaking Abstract at the annual meeting of the American Association

of Cancer Research (AACR), held in San Diego, California.

- Obtained ISO 13485:2003 certification for the design and development

of in-vitro diagnostic (IVD) test kits for the management of

colorectal disease status in a laboratory setting, following a

successful audit in December 2007.

- Expanded its Colorectal Cancer Clinical Advisory Board with the

appointme
'/>"/>

SOURCE GeneNews Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. GeneNews CSO Dr. CC Liew awarded state honour by the Government of Malaysia
2. GeneNews Chief Scientist Dr. C.C. Liew co-editor of new genomics reference book
3. GeneNews initiates patient sample accrual for validation studies of colon cancer blood test
4. GeneNews receives ISO 13485 accreditation
5. GeneNews selected to present late-breaking abstract at AACR Annual Meeting
6. GeneNews announces 2007 year end results
7. GeneNews reports positive results from validation study of colorectal cancer biomarkers in late-breaking abstract at AACR
8. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
9. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
10. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
11. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... made great strides in saving China,s endangered national treasure, ... 65 giant panda reserves that have been established and ... 1596 pandas remain in the wild. , Breeding ... the panda by improving genetic diversity, avoid inbreeding and ... are these high-profile programs doing so far? , In ...
(Date:7/23/2014)... 2014 /PRNewswire-iReach/ -- Think Drinks are a neuroscience-backed drink ... term. They are the first functional focus beverage to ... an alternative to the temporary fix associated with energy ... July 29, 2014, with hopes to raise $50,000 over ... - http://photos.prnewswire.com/prnh/20140723/129697 Think Drinks ...
(Date:7/23/2014)... year, Formedix celebrated its partnership with ... management solutions for clinical trials. The company launched its ... capture (EDC) and clinical data management. Formedix, a renowned ... TrialMaster to its Transform for EDC product line. This ... is being released this week, in response to market ...
(Date:7/23/2014)... (PRWEB) July 23, 2014 StemGenex® ... therapy in the US aimed at improving the lives ... newest clinical study for Parkinson’s disease. StemGenex believes ... stem cell therapy are paramount when providing care to ... study makes stem cell therapy accessible to the millions ...
Breaking Biology Technology:truBrain Neuroscientists To Launch More Effective, Healthier Alternative To Energy Drinks On Indiegogo 2Formedix and OmniComm Systems® Partnership Strengthened with the Release of Enhanced TrialMaster® Integration for EDC Build 2Formedix and OmniComm Systems® Partnership Strengthened with the Release of Enhanced TrialMaster® Integration for EDC Build 3StemGenex® Gives Hope to Parkinson’s Patients through New Stem Cell Clinical Study 2StemGenex® Gives Hope to Parkinson’s Patients through New Stem Cell Clinical Study 3
... BRANFORD, Connecticut and STATE COLLEGE, Pennsylvania, May 9, ... Roche Company, and SoftGenetics announced today that the ... designed to provide users of 454 Sequencing Systems ... options provided by SoftGenetics NextGENe® software. ...
... JERICHO, N.Y., May 8, 2012 Health Care ... response to continued recent devastating natural and man-made ... the HCCS online training course, "Bioterrorism and Disaster ... (Logo:  http://photos.prnewswire.com/prnh/20061010/NYTU194LOGO ) "HCCS ...
... COPENHAGEN, May 8, 2012  Ekahau ... Location Systems (RTLS), today announced the launch of its newest ... Pager .  The B4 features an OLED text display and multiple ... to acknowledge receipt or to initiate calls and alarms. A unique ...
Cached Biology Technology:Roche 454 Life Sciences and SoftGenetics Sign Co-Promotion Agreement for Next-Gen Sequencing Software Tools 2Roche 454 Life Sciences and SoftGenetics Sign Co-Promotion Agreement for Next-Gen Sequencing Software Tools 3Free Disaster Preparedness Online Training Course 2Ekahau Launches Next Generation Wi-Fi RTLS Staff Badge and Pager 2Ekahau Launches Next Generation Wi-Fi RTLS Staff Badge and Pager 3
(Date:7/23/2014)... This news release is available in German . ... shape and stability to cells, drive metabolic processes and ... into complex three-dimensional shapes. Scientists at the Max Planck ... that proteins can be constructed of similar amino acid ... suggests that the proteins that exist today arose from ...
(Date:7/23/2014)... Innovative Networking in personalized cancer medicine, (the WIN consortium), ... Thomas Jefferson University will be one of ... this prestigious group in the Tri-State Area. The goal ... personalized medicine to the patient by forging collaborations between ... participation in the WIN consortium means Jefferson cancer patients ...
(Date:7/23/2014)... As local and national governments struggle to deal with ... now refining the picture of just how much there ... the ACS journal Environmental Science & Technology , ... that developed countries discard floods into just seven developing ... people who live there. , Knut Breivik and colleagues ...
Breaking Biology News(10 mins):Protein evolution follows a modular principle 2New partnership brings more personalized cancer treatment to Philadelphia 2
... 2011) -- In a biotechnological tour de force, Rice ... for rapidly converting simple glucose into biofuels and petrochemical ... , Rice,s team described how it reversed one of ... beta oxidation cycle -- to engineer bacteria that produce ...
... Cambridge, Mass. - August 10, 2011 - Between conception ... meters long, looping and coiling within the tiny abdomen. ... loops into the same formationhowever, until now, it has ... experimental observations, biological and biophysical manipulations, theory, and computation, ...
... Genetically engineered spider silk could help overcome a major ... according to a new study that reported development and successful ... ACS, journal Bioconjugate Chemistry . David Kaplan and ... genes to prevent or treat disease requires safe and ...
Cached Biology News:Metabolism in reverse: Making biofuels at full-throttle pace 2Gut coils with help from its elastic neighbor 2Gut coils with help from its elastic neighbor 3
Goat polyclonal to Dysadherin ( Abpromise for all tested applications). entrezGeneID: 53827...
UBC13 Antibody...
... SAPK/JNK (Thr183/Tyr185) Antibody Kit Kit ... Catalog #9251, 200 ul SAPK/JNK (56G8) ... SAPK/JNK Cell Extracts, Catalog #9253, (4 ... Catalog #7074, 100 ul Anti-biotin IgG, ...
Vascular Endothelial Growth Factor C Class: Antibody Product Group: Angiogensis...
Biology Products: